These 5 Stocks Could Yield Huge Gains if Omicron Fears Recede




  • In Business
  • 2021-12-02 18:25:35Z
  • By GOBankingRates
dima_sidelnikov / iStock.
dima_sidelnikov / iStock.  

As the U.S. Centers for Disease Control and Prevention announced the first confirmed case of the Omicron variant in the U.S. on Wednesday, Dec. 1, the Dow Jones Industrial Average dipped by more than 461 points.

See: Moderna, GameStop and 8 More of the Hottest Stocks of 2021
Explore: Top 10 Most Expensive Stocks: What Is the Highest Priced Stock Right Now?

Investors and analysts are watching the market closely for "bargains" right now, and everyone from Jim Cramer (of "Mad Money") to the analysts at The Motley Fool are sharing their top picks in the face of growing Omicron fears.

If you're looking for a value proposition and have some money ready to invest, consider some of these stocks that experts are calling "buys" right now. It may be wise to plan to hold said investments for the longer term as they all have solid fundamentals and a bright future, according to the experts.

And if you're looking for a unique holiday gift, consider picking up one of these stocks for a loved one to give them a gift that will continue giving, potentially for years.

1. Disney

As a media and entertainment company, Disney stock took a hit as fears of the Omicron variant emerged. Advance ticket sales of "Spider-Man: No Way Home" continue breaking records, but advance sales will mean nothing if people are afraid to go to the theater.

Additionally, with Disney+ subscriber numbers falling short of projections, now - not later - is the time to buy Disney according to Cramer. Although Disney climbed slightly on the morning of Dec. 2 from its 52-week low at just over $142 on Dec. 1, there's still time to get in. Plus, if you have children or Disney / Star Wars / Avengers fans on your holiday wish list, Disney stock could make a great holiday gift that keeps on giving.

2. Teladoc Health

The Motley Fool is calling this telemedicine company "one of the biggest winners over the short term." It may be a bargain right now at $93.25, down from a high of about $285 in February 2021. However, this company also has staying power, the publication advises, deeming it "an exciting disruptor of health care." If the Omicron variant does progress into something worth worrying about, the telemedicine industry will likely see huge gains. And if economic recovery continues and the market rebounds quickly, Teladoc is still a solid long term buy, per Motley Fool analysts.

3. PayPal

Cramer is calling PayPal a buy, especially as it hovers in the low $180s. On Dec. 1 it dipped to $179, a 52-week low. Cramer urges investors to look past PayPal's less-than-stellar chart and consider the company's future growth and potential as a long-term investment.

More: Why Stocks Are the Perfect Gift for the Kid Who Has Everything

With a marquee name and a (relatively) low price, PayPal stock could make a fabulous stocking stuffer for your favorite online shopper, too.

4. MercadoLibre

Omicron variant or not, the past year has shown us that e-commerce isn't going away and will only continue to grow. Latin e-commerce and digital payments platform MercadoLibre opened low on Dec. 2, at $1,104.20, close to its 52-week low of $1,090.12. But the holiday season should bode well for this stock and you only need to look at its 52-week high of around $2,020 to see the potential as a long-term investment here. As The Motley Fool points out, "taking advantage of this dip should reward investors once again."

5. GameStop

GameStop stock took a dip in line with the market yesterday amidst Omicron fears, but it still sits at less than 50% of its 52-week high. Hovering around $180 and down 12% in the past five days, GameStop may present a buying opportunity. Plus, if you're looking for a great gift to get your teen or tween started in investing, bundle a print-out of their new stock option with their favorite video game, controller, or headphones. In spite of the controversy surrounding the original meme stock, GameStop stock continues to generate buzz and make headlines, making it an enticing investment, especially as a gift.

Learn: How To Invest In Entertainment-Related Stocks
Find: Don't Be Fooled: Retailers Could Be Boosting Stocks With Buybacks

As Bloomberg Businessweek noted on Dec. 1, people bought GameStop during the frenzy last winter not because of its "future cash flows," but to become part of a fun online community - for a sense of belonging and for nostalgia. All these things make this stock an interesting gift to get a child interested in investing.

  • How Much You Need To Be 'Rich' in 15 Major Vacation Destinations

  • 5 Nontraditional Ways To Build Your Wealth

  • How To Add $500 to Your Wallet Just in Time for the Holidays

  • 15 Mortgage Questions To Ask Your Lender

This article originally appeared on GOBankingRates.com: These 5 Stocks Could Yield Huge Gains if Omicron Fears Recede

COMMENTS

More Related News

COVID Infection More Protective Than Vaccines Amid CA Delta Surge
COVID Infection More Protective Than Vaccines Amid CA Delta Surge

Those who were previously sick with COVID-19 had more protection from delta than the vaccinated, California health officials said.

'Completely full' ICUs as omicron wave stresses hospitals; FDA expands use of remdesivir. Latest COVID-19 updates

In Alabama, cases have soared and ICUs are full. Most of Vermont's hospitals face critical staffing levels, a study found. COVID-19 updates.

Financial Advisors Hate This $79 Investment Tool, Which Has Beaten the Market for 19 Years in a Row
Financial Advisors Hate This $79 Investment Tool, Which Has Beaten the Market for 19 Years in a Row

Stock Advisor's average stock pick offers returns of 666%, and SPY readers can become members for $79/year.

Striking new data shows vaccines have protected New Yorkers very well against Omicron so far
Striking new data shows vaccines have protected New Yorkers very well against Omicron so far

Data for the weeks ending January 1 and 8 showed that when infections spiked citywide, vaccinated New Yorkers were less likely to get COVID-19.

GSK, Vir ramping up U.S. output of COVID antibody drug
GSK, Vir ramping up U.S. output of COVID antibody drug
  • US
  • 2022-01-21 17:19:09Z

The U.S. government last week signed a deal with the drugmakers to buy 600,000 more doses of the therapy, sotrovimab, for an undisclosed sum. The GSK-Vir...

Leave a Comment

Your email address will not be published. Required fields are marked with *

Cancel reply

Comments

Top News: Business